These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31639484)

  • 21. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
    Zeller T; Langhoff R; Rocha-Singh KJ; Jaff MR; Blessing E; Amann-Vesti B; Krzanowski M; Peeters P; Scheinert D; Torsello G; Sixt S; Tepe G;
    Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions.
    Zeller T; Lopez L; Pigott JP
    J Endovasc Ther; 2019 Jun; 26(3):333-341. PubMed ID: 31106694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results.
    Brodmann M; Werner M; Meyer DR; Reimer P; Krüger K; Granada JF; Jaff MR; Schroeder H;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2357-2364. PubMed ID: 30522663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial.
    Debing E; Aerden D; Vanhulle A; Gallala S; von Kemp K;
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):528-534. PubMed ID: 27727202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of juxta-anastomotic stenoses for failing distal radiocephalic arteriovenous fistulas: Drug-coated balloons versus angioplasty.
    Patanè D; Failla G; Coniglio G; Russo G; Morale W; Seminara G; Calcara G; Bisceglie P; Malfa P
    J Vasc Access; 2019 Mar; 20(2):209-216. PubMed ID: 30165791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
    JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, risk, and treatment of binary restenosis after vertebral artery stenting.
    Qiu Z; Liu J; Huang R; Liu D; Dai Z; Luo M; Jiang Y
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):404-409. PubMed ID: 32277795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-coated balloon dilation before carotid artery stenting of post-carotid endarterectomy restenosis.
    Piccoli G; Biondi-Zoccai G; Gavrilovic V; Radici V; Cancelli I; Frigatti P; Frati G; Marullo AG; Divis P; Gasparini D
    J Endovasc Ther; 2015 Apr; 22(2):212-6. PubMed ID: 25809364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review of drug eluting balloon angioplasty for arteriovenous haemodialysis access stenosis.
    Khawaja AZ; Cassidy DB; Al Shakarchi J; McGrogan DG; Inston NG; Jones RG
    J Vasc Access; 2016; 17(2):103-10. PubMed ID: 26847736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with vertebral artery origin stenting and ostium dilatation: results of treatment and clinical outcomes.
    Rangel-Castilla L; Gandhi S; Munich SA; Cress MC; Sonig A; Krishna C; Hopkins LN; Snyder KV; Levy EI; Siddiqui AH
    J Neurointerv Surg; 2016 May; 8(5):476-80. PubMed ID: 25838198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
    J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of Scoring Balloons on Percutaneous Transluminal Angioplasty Outcomes in Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Inoue N
    J Endovasc Ther; 2020 Jun; 27(3):481-491. PubMed ID: 32249658
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-Coated versus Plain Balloon Angioplasty in Bypass Vein Grafts (the DRECOREST I-Study).
    Björkman P; Kokkonen T; Albäck A; Venermo M
    Ann Vasc Surg; 2019 Feb; 55():36-44. PubMed ID: 30092443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Drug-Eluting Balloon and Standard Balloon Angioplasty for Infrapopliteal Arterial Diseases in Diabetic Patients.
    Oz II; Serifoglu I; Bilici M; Altinbas NK; Oz EB; Akduman EI
    Vasc Endovascular Surg; 2016 Nov; 50(8):534-540. PubMed ID: 28081691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
    Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.